Stemnion quietly moves into new research digs, offering new hope for healing skin
Regenerative medicine company Stemnion has opened a new 20,000 square foot lab and research space to pursue the development of regenerative tissue repair technologies in the Pittsburgh Technology Center.
The space, which includes two clean rooms, offices and a cell processing facility for clinical research and the production of tissue repair technologies, was made possible through $2 million provided by Allegheny County as well as the state and federal government. Congressman Mike Doyle, State Sen. Jay Costa and Dan Onorato were instrumental in helping to secure the funds, the company says.
Stemnion has been quietly working under the radar in Pittsburgh since 2004, developing cell-based therapeutic products that hope to offer treatment for burn patients, war wounds and diabetes patients, which alone affects some 20 million Americans. The company is in the process of obtaining FDA approvals.
“The research and clinical translation that will be conducted in this new facility has the potential to radically improve treatment and rehabilitation for acute and chronic wounds,” says CEO George Sing. “This wouldn’t have been possible without the support of federal, state, local governments and private industry.”